Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RASIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RALGDS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CREBBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR8B8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC92 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBCB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAMA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HECTD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INPP5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTAN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPIRE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC24A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on